India to Russia: Cabazitaxel Export Trade Route

The India to Russia Cabazitaxel corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $2.4M USD. The route is dominated by JODAS EXPOIM PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's cabazitaxel manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $592.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with cabazitaxel's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 24.3%, placing it at rank #12 among India's top cabazitaxel export destinations globally.

On the import side, key buyers of Indian cabazitaxel in Russia include OOO"JODAS EXPOIM", AO NPC ELFA RUSSIA, MAKIZ PHARMA LIMITED. OOO"JODAS EXPOIM" is the single largest importer with 1 shipments valued at $2.4M USD.

India's cabazitaxel exports to Russia are driven primarily by a handful of large-scale manufacturers. JODAS EXPOIM PRIVATE LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Russia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — JODAS EXPOIM PRIVATE LIMITED, R R PHARMACEUTICALS PVT LTD, HETERO LABS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $592.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as cabazitaxel elfaconcentrate for solution for infusion 60mg b.no. 23gcz01 m:07/23,e:06/25 and cabazitaxel elfa solventsolvent for concentrate for solution for infusion 60mg b.no. 23gxc01 m:07/23,e:06/25, suggesting that buyers in Russia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, OOO"JODAS EXPOIM" is the largest importer with 1 shipments worth $2.4M USD — representing 100% of all cabazitaxel imports from India on this route.